LEADER 02419cas a2200505 i 4500001 99127161670306421 005 20220107145657.0 006 m o d f 007 cr ||||||||||| 008 100628d1976201umdu x o f0 0eng c 010 2022233608 035 (CKB)5470000002528135 035 (OCoLC)644143558 |z(OCoLC)608575536 035 (EXLCZ)995470000002528135 040 OCLCE |beng |erda |epn |cOCLCE |dOCLCQ |dOCLCF |dOCLCQ |dNTE |dINARC |dOCLCO |dOCLCQ |dOCLCO |dOCLCA |dOCLCQ |dGPO 042 dlrpcc 043 n-us--- 060 4 QH 438.7 N277 1982 110 2 National Institutes of Health (U.S.), |eauthor. 245 10 Guidelines for research involving recombinant DNA molecules. 246 1 NIH guidlines 246 1 NIH guidlines for research involving recombinant DNA molecules |f 264 1 [Bethesda, Md.] : |bNational Institutes of Health 300 1 online resource (volumes) 310 Irregular 336 text |btxt |2rdacontent 337 computer |bc |2rdamedia 338 online resource |bcr |2rdacarrier 362 1 Began with 1976; ceased publication. 588 0 Print version record. 588 1 October 2011 (Internet Archive, OBA, viewed Jan. 7, 2022). 515 Each issue supersedes all previous issues. 650 0 Recombinant DNA |xResearch |xLaw and legislation |zUnited States. 770 0 National Institute of Allergy and Infectious Diseases (U.S.). Office of Recombinant DNA Activities. |tAdministrative practices supplement to the NIH guidelines for research involving recombinant DNA molecules 785 00 National Institutes of Health (U.S.). |tNIH guidelines for research involving recombinant or synthetic nucleic acid molecules (NIH guidelines) |w(DLC) 2022233607 |w(OCoLC)1291284645 906 JOURNAL